Diplomat receives limited distribution contract for Imbruvica (ibrutinib)
Flint, Mich. –Nov. 14, 2013 — Diplomat, the country’s largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA™ (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration (FDA) for the treatment of Mantle Cell Lymphoma (MCL).
IMBRUVICA™, a Brutton’s Tyrosine Kinase (BTK) Inhibitor, is an oral drug available in 140 mg, 90 capsule bottles and 140 mg, 120 capsule bottles. Full prescribing information is available at www.IMBRUVICA.com.
“We are pleased to partner with Pharmacyclics and Janssen Biotech, Inc. as a specialty pharmacy provider of IMBRUVICA™,” said Gary Kadlec, R.Ph., President of Diplomat. “Diplomat has proven expertise in handling limited distribution drugs and an industry-wide reputation for comprehensive patient care outreach that improves patient compliance, adherence and outcomes.”
Diplomat’s high-tech, high-touch approach, which achieved 98% patient and prescriber satisfaction ratings in 2012, includes timely prescription delivery, side effect management support and 24 hour access to pharmacists and other specialists on the continuum of care. For IMBRUVICA™, Diplomat will also provide prior authorization management, co-pay support, and assistance to patients that meet certain financial criteria.
IMBRUVICA™ is commercially available immediately.
Contact: Barbara Fornasiero, EAFocus Communications: 586.817.8414, email@example.com; Jim Kosmerick, Diplomat: 810.768.9530, JKosmerick@diplomatpharmacy.com; Gary Rice, R.Ph., Diplomat: 810.768.9863, GRice@diplomatpharmacy.com
@DiplomatRxWe are #hiring sales consultants for both NYC and Oakland, California! Come check it out. https://t.co/GDqMaItrsZ5 days ago
@gchabitatRT @gchabitat: Do you have what it takes to be a Habitat Olympian? Join us at @DiplomatRx on 5/5 to find out! https://t.co/5eq5y94hv36 days ago
@DiplomatRxDiplomat Will Dispense ZEJULA™ to Treat Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer… https://t.co/MnQRQdLufl1 week ago
@DiplomatRxFar more than an adventure, their trip was dedicated to assisting people living with #hemophilia… https://t.co/kngmnkvjvU2 weeks ago
@DiplomatRxDiplomat to Release First Quarter 2017 Operating Results and Host Conference Call on Monday, May 8, 2017… https://t.co/h6vJR7823O2 weeks ago